Amogy and Trafigura to study use of ammonia as a carrier to transport clean hydrogen

Business Developments & Projects

US-based ammonia power solutions company Amogy has entered into an agreement with Swiss commodity trader Trafigura to study the use of ammonia as a carrier to transport clean hydrogen from point of production to point of consumption.

Courtesy of Amogy

The finding of this joint research will help support industry-wide efforts to decarbonise transport and heavy industrial processes and lower carbon emissions to meet global climate goals, the partners said.

Under the agreement, Amogy and Trafigura seek to identify and assess scenarios in which ammonia cracking technology can be deployed to support the growing hydrogen market, starting with Europe which is targeting 20 million tonnes of hydrogen consumption by 2030.

Using economic models and energy demand forecasts, the two companies will determine the viability and cost-effectiveness of industrial-scale ammonia crackers.

Related Article

“Our partnership with Trafigura opens up tremendous opportunities for the Amogy team to better understand and explore our platform’s potential benefits at scale“, said Seonghoon Woo, chief executive and co-founder at Amogy. “We look forward to collaborating with Trafigura to identify opportunities for large-scale ammonia cracking to enable global transportation of hydrogen.”

“At Trafigura, we recognize that hydrogen will need to be transported over long distances, from regions rich in renewable power to demand hubs. Ammonia is a cost-competitive carrier of hydrogen which will require cracking at a destination to cater to different end uses”, stated Margaux Moore, head of Energy Transition Research at Trafigura.

“We believe ammonia cracking will be a key enabling technology for the large-scale uptake of clean hydrogen. Our work with Amogy will help us understand the economics of this supply chain, to deliver the most competitive low carbon hydrogen to our customers.

Related Article

Read more about latest hydrogen-related developments